Home › Cancer (all types) › NCT06858449

Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer

NeoChemoPRT: A Randomized Study of Resistance Training and Post-Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer

Who can join

Ages 20 to 89 · Women

Inclusion Criteria:

1. Age 20-89 years
2. Women with a biopsy proven diagnosis of invasive carcinoma of the breast.
3. Women must undergo neoadjuvant chemotherapy for breast cancer treatment prior to surgery
4. Must be able to read and understand English and consent for themselves.

Exclusion Criteria:

1. Inability to get up and down off the ground or squat body weight
2. Inability to safely engage in group exercise sessions as deemed by study PI
3. Severe arthritic, joint, cardiovascular, musculoskeletal, or any other condition deemed by PI to be unsafe to engage in resistance training
4. Lactose intolerance
5. Cow's milk or whey protein allergy
6. Pregnant women
7. Males

About the study

In this study, the investigators hypothesize that a high dose of post-workout protein nutrition regimen focused on food quality and an observed exercise regimen utilizing high-load resistance training initiated during or after cancer treatment will improve body composition and functional capacity.

What is being tested

• Whey protein (20 grams) (dietary supplement)
• Whey protein (60 grams) (dietary supplement)

Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Participants: 30 · Started: Jan 2, 2025

Contact the study team

• Clinical Trials Contact · Phone: 412-330-6151

Official record on ClinicalTrials.gov — NCT06858449

Locations in the U.S.

Conditions

• Cancer (all types)
• Breast Cancer

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.